Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roos van Westrhenen is active.

Publication


Featured researches published by Roos van Westrhenen.


Blood Purification | 2007

Cyclosporin A Induces Peritoneal Fibrosis and Angiogenesis during Chronic Peritoneal Exposure to a Glucose-Based, Lactate-Buffered Dialysis Solution in the Rat

Roos van Westrhenen; Jan Aten; Najat Hajji; Onno J. de Boer; Cindy Kunne; Dirk R. de Waart; Raymond T. Krediet

Background/Aims: Cyclosporin A (CsA) stimulates the development of fibrosis. We investigated whether CsA contributes to peritoneal alterations induced by long-term exposure to dialysis solutions. Methods: Ten rats received peritoneal infusion of dialysis solution and oral CsA for 8 weeks. Eight received only the dialysis solution (controls). Peritoneal function was assessed at 8 weeks followed by sacrifice. The number of vessels was counted, fibrosis was assessed and hydroxyproline was determined. PCR was performed for vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF) and transforming growth factor-β (TGF-β). Results: Histology revealed more fibrosis, hydroxyproline and vessels (thick walled) in CsA-exposed animals. Peritoneal transport was not different. The mRNA content of TGF-β, CTGF and VEGF was higher in CsA. Conclusion: CsA combined with exposure to dialysis solutions was associated with increased peritoneal fibrosis and angiogenesis.


Ndt Plus | 2008

Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD

Raymond T. Krediet; Machteld M. Zweers; Roos van Westrhenen; Agnes Zegwaard; Dirk G. Struijk

Background. Long-term peritoneal dialysis (PD) may lead to functional and morphologic changes in the peritoneal membrane, probably because of the continuous exposure to conventional dialysis solutions. Methods. The morphologic changes include neoangiogenesis and fibrosis. The authors of this article developed a long-term peritoneal exposure model in rats, in which the morphological alterations could be induced after daily peritoneal infusion of a 3.86% glucose/lactate-buffered conventional PD solution. Results and Conclusions. In the present article, a review of the model and of the results obtained with various available and experimental solutions is given. It appeared that high lactate concentrations contributed to the glucose-induced neoangiogenesis by pseudohypoxia. Glucose degradation products were probably more important in the induction of peritoneal fibrosis. The promising results of a combination of amino acids, glycerol and glucose, each in a low concentration, buffered with either pyruvate or bicarbonate/lactate, are presented and discussed. The combination of glycerol, amino acids and dextrose, dissolved in a bicarbonate/lactate buffer (GLAD), may be an option for a new generation of dialysis fluids.


Peritoneal Dialysis International | 2004

Does lymphatic absorption change with the duration of peritoneal dialysis

Wieneke M. Michels; Machteld M. Zweers; Watske Smit; Korevaar Jc; Dirk G. Struijk; Roos van Westrhenen; Raymond T. Krediet


Peritoneal Dialysis International | 2008

A PYRUVATE-BUFFERED DIALYSIS FLUID INDUCES LESS PERITONEAL ANGIOGENESIS AND FIBROSIS THAN A CONVENTIONAL SOLUTION

Roos van Westrhenen; Machteld M. Zweers; Cindy Kunne; Dirk R. de Waart; Allard C. van der Wal; Raymond T. Krediet


Peritoneal Dialysis International | 2004

Assessment of peritoneal fibrosis by conventional light microscopy and hydroxyproline measurements.

Roos van Westrhenen; Dirk R. de Waart; Sema Akman; Raymond T. Krediet


Peritoneal Dialysis International | 2006

ALPHA-2-MACROGLOBULIN AND ALBUMIN ARE USEFUL SERUM PROTEINS TO DETECT SUBCLINICAL PERITONITIS IN THE RAT

Roos van Westrhenen; Wytske Westra; Jacob van den Born; Raymond T. Krediet; Eelco D. Keuning; Johan K. Hiralall; Cindy Dragt; Liesbeth H. P. Hekking


Peritoneal Dialysis International | 2008

Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solution

Roos van Westrhenen; Anniek Vlijm; Johan K. Hiralall; Raymond T. Krediet


Peritoneal Dialysis International | 2003

WHAT CAN WE DO TO PRESERVE THE PERITONEUM

Raymond T. Krediet; Machteld M. Zweers; Roos van Westrhenen; Marja M. Ho-dac-Pannekeet; Dirk G. Struijk


Advances in peritoneal dialysis. Conference on Peritoneal Dialysis | 2003

The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.

Sema Akman; Roos van Westrhenen; Dirk R. de Waart; Johan K. Hiralall; Machteld M. Zweers; Raymond T. Krediet


Acta Paediatrica | 2002

Clinical advantages of new peritoneal dialysis solutions

Raymond T. Krediet; Roos van Westrhenen; Machteld M. Zweers; D. G. Struijck

Collaboration


Dive into the Roos van Westrhenen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cindy Kunne

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anniek Vlijm

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge